Published on

To Oppose Trump Politicizing of Covid-19, DC Rally to Demand "People's Vaccine" Be Free and Accessible to All

"Our best chance of staying safe is to ensure a Covid-19 vaccine is available for all as a common good."

A graphic promoting the Mourn, March & Movement for a People's Vaccine

A graphic promoting the Mourn, March & Movement for a People's Vaccine: Safe and Effective for All rally set for Oct. 21 in Washington, D.C.

Amid ongoing concerns about the Trump administration's handling of the coronavirus crisis and corporate control and profiteering, a coalition of progressive groups on Wednesday renewed the demand for a "people's vaccine" and announced a rally for next week touting the potential medication as a "critical health step toward global health equity."

"Our best chance of staying safe is to ensure a Covid-19 vaccine is available for all as a common good," organizers say in a call to action.

Set for October 21 outside the Department of Health and Human Services in Washington, D.C., the socially distanced event is dubbed "Mourn, March, and Movement for a People's Vaccine."

Organizers include Free The Vaccine for Covid-19, Public Citizen, Right 2 Health, Spaces in Action, and Universities Allied for Essential Medicines (UAEM), with other groups including Social Security Works and Health GAP backing the mobilization. The rally is set to take place a day before the next FDA hearing on October 22, 2020 focused on the development and authorization of potential Covid-19 vaccines.

The groups are demanding that a future coronavirus vaccine be shown to be safe and effective and be produced through widespread sharing of knowledge and technology in order to guarantee the vaccine is accessible to all.

That's not the path being pursed by the White House, say organizers. They explain:

WE'RE FIGHTING AGAINST the Trump Administration using an unproven and unsafe vaccine to steal the election • Global vaccine apartheid in which high income countries buy their way to the front of the line and leave the world's poor behind • White House maneuvers to undermine science and contradict respected experts at FDA, CDC, WHO, and NIH.


Never Miss a Beat.

Get our best delivered to your inbox.

Indeed, the Trump administration has faced sustained criticism for pushing for pre-Election Day approval of a coronavirus vaccine in an apparent political effort, and has embraced a "herd immunity" approach health experts condemn.

President Donald Trump has also refused to participate in the international vaccine pact called Covid-19 Vaccines Global Access led in part by the WHO, spurring outrage from developing countries.

United Nations Secretary-General António Guterres took an indirect jab at Trump last month, saying, "To think that we can preserve the rich people, and let the poor people suffer, is a stupid mistake."

Meanwhile, an Oxfam analysis released last month showed that a handful of rich nations representing a mere 13 percent of the world's population have bought up more than half of the promised Covid-19 vaccine doses.

The "Mourn, March, and Movement" rally announcement follows vocal demands for a so-called people's vaccine from former global leaders, health experts, and groups like Oxfam.

In a statement last month, Chema Vera, interim executive director of Oxfam International, called on companies to "share their knowledge free of patents and to get behind a quantum leap in production to keep everyone safe."

"We need a people's vaccine," said Vera, "not a profit vaccine."

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.

Please select a donation method:

Share This Article